Hemispherx Biopharma., has announced its for the first quarter of FY-2015.
The results shows EPS remains stable -$0.02 YoY, whereas cash and cash Assets were improved from $16.108 Million to $17.005 Million YoY.
View the full earnings release here.
Hemispherx Biopharma., has announced its for the first quarter of FY-2015.
The results shows EPS remains stable -$0.02 YoY, whereas cash and cash Assets were improved from $16.108 Million to $17.005 Million YoY.
View the full earnings release here.